Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Oct 11, 2024
Date Accepted: Jul 21, 2025
Evolving Digital Health Technologies: Aligning with and Enhancing the NICE Evidence Standards Framework – A Viewpoint Piece
ABSTRACT
The rapid advancement of AI-driven diagnostics and wearable health technologies is revolutionising healthcare delivery by enabling real-time health monitoring and early disease detection. This paper explores the current National Institute for Health and Care Excellence (NICE) Evidence Standards Framework (ESF) guidelines and evaluates the barriers to integrating Digital Health Technologies (DHTs) into the existing health and care system. These innovations are driving a shift towards personalised medicine, where interventions are tailored to individual patient profiles with unprecedented precision. NICE developed the ESF for DHTs to provide clear and consistent guidelines for assessing the efficacy, safety, and economic value of new digital health innovations. This paper posits that the NICE ESF should undergo strategic updates to remain relevant and effective in the face of rapidly advancing technologies, particularly those that evolve continuously through machine learning and real-world data integration. We propose that the NICE ESF transitions to a more dynamic, adaptive model, co-designed with industry partners to incorporate real-world evidence strategies. By promoting transparency, efficiency, and collaborative innovation, the framework can better support the integration of AI-based diagnostics and wearables into healthcare systems, ultimately improving patient outcomes and optimising healthcare performance.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.